- Home
- JXG vs TNON Comparison
JXG vs TNON Comparison
Compare JXG & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JXG | TNON |
|---|---|---|
| Founded | N/A | 2012 |
| Country | China | United States |
| Employees | N/A | 27 |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 7.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JXG | TNON |
|---|---|---|
| Price | $3.77 | $0.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 2.0K | ★ 149.5K |
| Earning Date | 05-14-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $69.93 |
| Revenue Next Year | N/A | $48.34 |
| P/E Ratio | $0.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.64 |
| 52 Week High | $10.29 | $2.48 |
Technical Indicators
Market Signals| Indicator | JXG | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 45.96 | 39.40 |
| Support Level | $3.70 | $0.64 |
| Resistance Level | $4.39 | $0.91 |
| Average True Range (ATR) | 0.24 | 0.07 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 53.47 | 14.74 |
Price Performance
Historical ComparisonAbout JXG JX Luxventure Limited
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.